Volume 17, Issue 4

Pharmacist recommendations for prophylactic enoxaparin monitoring and dose adjustment in trauma patients admitted to a surgical intensive care unit

Ali Scrimenti, Robert W. Seabury, Christopher D. Miller, Lucy Ruangvoravat, William Darko, Luke A. Probst, Gregory M. Cwikla

pp. 1541 · DOI: 10.18549/PharmPract.2019.4.1541 · Published Oct-Dec 2019

Background: There is limited information describing pharmacist participation in prophylactic enoxaparin monitoring in the surgical intensive care unit (SICU). Objective: Our study sought to: 1) characterize pharmacist re…

Characteristics of significant events identified by pharmacy students while on early immersion pharmacy practice experiences

Philip T. Rodgers, Vivian Cheng, Antonio A. Bush, Charlene Williams

pp. 1571 · DOI: 10.18549/PharmPract.2019.4.1571 · Published Oct-Dec 2019

Objective: The purpose of this study was to characterize and classify significant events of pharmacy students who completed an early practice experience. Methods: Significant event analyses (SEAs) were reflections submit…

Facilitators and barriers in implementing medication safety practices across hospitals within 11 European Union countries

Carita Linden-Lahti, Anna-Riia Holmström, Pirjo Pennanen, Marja Airaksinen

pp. 1583 · DOI: 10.18549/PharmPract.2019.4.1583 · Published Oct-Dec 2019

Background: The study was carried out as part of the European Network for Patient Safety (EUNetPas) project in 2008-2010. Objective: To investigate facilitators and barriers in implementation process of selected medicati…

Medication follow-up in newborns with extremely low birth-weight

Catarine Vitor Loureiro, Marta Maria de França Fonteles, Mylenne Borges Jácome Mascarenhas, Elana Figueiredo Chaves, Paulo Yuri Milen Firmino

pp. 1584 · DOI: 10.18549/PharmPract.2019.4.1584 · Published Oct-Dec 2019

Objective: The medication follow-up in infants with extremely low birth-weight in a neonatal intensive care unit is described, identifying drug-related problems (DRP), drug-related negative outcomes, and the relationship…

Combination therapy with once-weekly glucagon like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a case series

Estela Lajthia, John D. Bucheit, Pramit A. Nadpara, Dave L. Dixon, Lauren M. Caldas, Michael Murchie, Evan M. Sisson

pp. 1588 · DOI: 10.18549/PharmPract.2019.4.1588 · Published Oct-Dec 2019

Background: National treatment guidelines recommend glucagon-like peptide receptor agonists (GLP-1 RAs) as add-on therapy to oral agents. However, GLP-1 RAs in combination with dipeptidyl peptidase-4 (DPP-4) inhibitors i…

Drug and therapeutics committees in Jordanian hospitals: a nation-wide survey of organization, activities, and drug selection procedures

Qais Alefan, Somayya Alshareef, Samah Al-Shatnawi

pp. 1590 · DOI: 10.18549/PharmPract.2019.4.1590 · Published 3 November 2019

Background: Drug and Therapeutics Committees (DTCs) were founded about a century ago as a guide for dealing with drugs in hospitals. Since then, it has shown a vital role in rational drug use in terms of regulatory and e…

A nationwide web-based survey of a sample of Italian community pharmacists' perceptions and opinions about online sales of medicines and falsified drugs

Simona Lombardo, Franca Marino, Marco Cosentino

pp. 1593 · DOI: 10.18549/PharmPract.2019.4.1593 · Published 30 November 2019

Background: Throughout Europe, legal online pharmacies increasingly sell online drugs as well as other products such as dietary supplements. Online sale of pharmaceuticals however is closely connected to the phenomenon o…

Antibiotic prescribing for acute uncomplicated cystitis in Lebanese community pharmacies using a simulated patient

Sally G. Yaacoub, Valerie Koyess, Nathalie Lahoud, Deema Rahme, Nicole Francis, Nadine Saleh, Patrick Maison

pp. 1604 · DOI: 10.18549/PharmPract.2019.4.1604 · Published 12 December 2019

Background: Urinary tract infections are considered as one of the most frequent bacterial infections in the community and hospital settings. In this era of increasing antimicrobial resistance, antimicrobial stewardship h…

Appraisal of the entrustable professional activities (EPAs) patient care provider domain by North Dakota pharmacists

David M. Scott, Michael P. Kelsch, Macey Hanel, Daniel L. Friesner

pp. 1607 · DOI: 10.18549/PharmPract.2019.4.1607 · Published 1 December 2019

Background: Entrustable Professional Activities (EPAs) are the latest addition to a list of professional competencies that pharmacy educational organizations support, and accreditation organizations require, for assessme…

Factors associated with quality of life among community pharmacists in Lebanon: results of a cross-sectional study

Hala Sacre, Sahar Obeid, Georges Choueiry, Eva Hobeika, Rita Farah, Aline Hajj, Marwan Akel, Souheil Hallit, Pascale Salameh

pp. 1613 · DOI: 10.18549/PharmPract.2019.4.1613 · Published 28 October 2019

Objective: The objective of this study was to assess the quality of life and the factors associated with it among community pharmacists in Lebanon. Methods: This cross-sectional study was carried out between March and Ju…

Development and validation of an instrument designed to measure factors influencing physician prescribing decisions

Mohsen Ali Murshid, Zurina Mohaidin, Mohammad Zayed

pp. 1616 · DOI: 10.18549/PharmPract.2019.4.1616 · Published 14 December 2019

Background: Previous attempts to develop an instrument to measure factors that influence prescribing decisions among physicians were relatively insufficient and lacked validation scale. Objective: We present a new tool t…

A comparison of clinical pharmacist management of type 2 diabetes versus usual care in a federally qualified health center

Rhianna M. Fink, Emanuela V. Mooney, Joseph J. Saseen, Sarah J. Billups

pp. 1618 · DOI: 10.18549/PharmPract.2019.4.1618 · Published 3 December 2019

Background: Clinical pharmacists have demonstrated their ability to improve patient outcomes over usual care for patients with type 2 diabetes and glycemic levels above goal, though reasons for this are not well defined.…

Challenges with accessing health care for young children presumed to have malaria in the rural district of Butaleja, Uganda: a qualitative study

Asa Rahimi, Rosemin Kassam, Zhong Dang, Richard Sekiwunga

pp. 1622 · DOI: 10.18549/PharmPract.2019.4.1622 · Published 4 December 2019

Objective: A qualitative study was conducted to gain insight into challenges reported by Butaleja households during a previous household survey. Specifically, this paper discusses heads of households’ and caregivers’ per…

Creation and validation of a semi-quantitative instrument to assess the confidence of pharmacists in medication consultation for patients with depression: The pharmacists' confidence scale about medication consultation for depressive patients (PCMCD)

Masaki Shoji, Atsuko Fujiwara, Mitsuko Onda

pp. 1628 · DOI: 10.18549/PharmPract.2019.4.1628 · Published 4 December 2019

Objectives: To develop a semi-quantitative instrument to assess pharmacists’ confidence in medication counseling for patients with depression, The Pharmacists' Confidence scale about Medication Consultation for Depressiv…

A comprehensive view of knowledge and osteoporosis status among type 2 diabetes mellitus in Malaysia: A cross sectional study

Shaymaa A. Abdulameer, Mohanad N. Sahib, Syed A. Syed Sulaiman, Mohamed A. Hassali

pp. 1636 · DOI: 10.18549/PharmPract.2019.4.1636 · Published 13 December 2019

Background: osteoporosis and diabetes mellitus are highly prevalent diseases that have potentially devastating effects on health and socioeconomic status. Objective: The aims of this study were to assess: 1) the level of…

Use of secret simulated patient followed by workshop based education to assess and improve inhaler counseling in community pharmacy in Jordan

Eman R. Elayeh, Eman A. Hammad, Razan H. Tubeileh, Iman A. Basheti

pp. 1661 · DOI: 10.18549/PharmPract.2019.4.1661 · Published 17 December 2019

Objectives: To assess inhaler technique demonstration skills of community pharmacists located in Amman, Jordan via incorporating the trained secret simulated patient (SSP) approach. Secondly, to evaluate the effectivenes…

Real-world study of direct oral anticoagulant dosing patterns in patients with atrial fibrillation

Whitney L. Gustafson, John Saunders, Sara R. Vazquez, Aubrey E. Jones, Daniel M. Witt

pp. 1709 · DOI: 10.18549/PharmPract.2019.4.1709 · Published Oct-Dec 2019

Background: Direct oral anticoagulants (DOACs) are preferred for stroke prevention in atrial fibrillation (AF). However, off-label doses have been associated with increased risk of adverse events. Objective: The objectiv…

Role of board certification in advancing pharmacy practice

Samuel G. Johnson

pp. 1767 · DOI: 10.18549/PharmPract.2019.4.1767 · Published 8 December 2019